Statement Of Financial Position [Abstract]

Medistim - Filing #2583905

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
51 312 NOK
58 862 NOK
Deferred tax assets
3 591 NOK
3 240 NOK
Cash and cash equivalents
144 164 NOK
124 866 NOK
Assets
482 659 NOK
403 244 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 585 NOK
4 585 NOK
Retained earnings
285 350 NOK
240 160 NOK
Share premium
41 852 NOK
41 852 NOK
Treasury shares
21,000 NOK
26,000 NOK
Other reserves
17 184 NOK
6 138 NOK
Equity
367 691 NOK
16 797 NOK
41 852 NOK
285 736 NOK
21,000 NOK
4 585 NOK
65 158 NOK
302 533 NOK
18 742 NOK
26,000 NOK
240 160 NOK
6 138 NOK
13 344 NOK
306 052 NOK
246 298 NOK
59 754 NOK
41 852 NOK
4 585 NOK
203 899 NOK
204 680 NOK
52 165 NOK
5 762 NOK
4 585 NOK
33,000 NOK
781,000 NOK
41 852 NOK
256 845 NOK
Liabilities [abstract]
Liabilities
114 967 NOK
97 192 NOK
Equity and liabilities
482 659 NOK
403 244 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.